Jennifer L. Dotson
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
160
Citations
1,277
Est. group size
~3
Recurring co-author estimate
Active years
20
Publishing since 2007
Jennifer L. Dotson's research focuses on pediatric inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis in children and adolescents. Her work examines treatment approaches such as anti-TNF and biosimilar therapies, drug monitoring, disease imaging and biomarkers, healthcare costs, and care transitions for young patients moving into adult care. Much of the research is clinically oriented, drawing on cohort studies and healthcare utilization data to inform treatment and care delivery practices.
Publication output grew from a low base in 2017 to a peak around 2021 and has remained relatively steady at 15-18 papers per year since then.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- P-1441. Inadequate Responses to Influenza Vaccination in Adolescents with Inflammatory Bowel Disease (IBD): Making the Case for Improved Strategies
Open Forum Infectious Diseases · 2026
- The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn’s Disease Complications in Children
The American Journal of Gastroenterology · 2026
- Treatment patterns among pediatric and adult patients with ulcerative colitis in the United States: a retrospective cohort study
Current Medical Research and Opinion · 2026
- Guidance for the Primary Care Provider in Identifying Infants With Biliary Atresia by 2–4 Weeks of Life: Clinical Report
PEDIATRICS · 2025
- Pediatric Gastrointestinal Tract Outcomes During the Postacute Phase of COVID-19
JAMA Network Open · 2025
- Predictors of antitumor necrosis factor primary nonresponse and drug durability in pediatric inflammatory bowel disease
Journal of Pediatric Gastroenterology and Nutrition · 2025
- National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease
JPGN Reports · 2025
- Healthcare resource utilization and cost trends in pediatric inflammatory bowel disease within an accountable care organization
Journal of Pediatric Gastroenterology and Nutrition · 2025
- Baseline terminal ileal CT and MRI measurements are associated with imaging outcomes in pediatric Crohn’s disease: a cohort study
Pediatric Radiology · 2025
- The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance
The American Journal of Managed Care · 2025
- P0421 Clinical validity of a seroproteomic index of endoscopic activity in pediatric Crohn’s disease
Journal of Crohn s and Colitis · 2025
- P-2108. Risk Factors for Indeterminate Tuberculosis (TB) Testing Results Among Immunocompromised Children in an Area of Low TB Endemicity
Open Forum Infectious Diseases · 2025
- The Transition Care Index: Standardizing comprehensive transition and transfer for young adults with inflammatory bowel disease
JPGN Reports · 2025
- Su1902: CLINICAL VALIDITY OF A SEROPROTEOMIC INDEX OF ENDOSCOPIC ACTIVITY IN PEDIATRIC CROHN’S DISEASE
Gastroenterology · 2025
- Crohn’s Disease
Elsevier eBooks · 2025
- Inflammatory Bowel Diseases×24
- Gastroenterology×21
- Journal of Pediatric Gastroenterology and Nutrition×18
- JPGN Reports×7
- Cureus×4
- Hilary K. Michel
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ross Maltz
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Brendan Boyle
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Antonia Boger-May
Biochemistry, Genetics and Molecular Biology · Indiana University
- Bin Dong
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile